Novartis aims to nearly triple biosimilar drugs on market by 2020 – Reuters

Posted by on Jun 20th, 2016 and filed under Alerts & Updates. You can follow any responses to this entry through the RSS 2.0. Responses are currently closed, but you can trackback from your own site.

Novartis aims to nearly triple biosimilar drugs on market by 2020 – Reuters



Reuters
Novartis aims to nearly triple biosimilar drugs on market by 2020
Reuters
KUFSTEIN, Austria Switzerland's Novartis pledged to nearly triple its number of biosimilar drugs on the market by 2020, raising its bet that cheaper versions of blockbuster cancer and immune system medicines will snatch billions in rivals' profits

and more »

Novartis aims to nearly triple biosimilar drugs on market by 2020 – Reuters Reuters Novartis aims to nearly triple biosimilar drugs on market by 2020ReutersKUFSTEIN, Austria Switzerland's Novartis pledged to nearly triple its number of biosimilar drugs on the market by 2020, raising its bet that cheaper versions of blockbuster cancer and immune system medicines [...]

Comments are closed

  • Copyright 2011, www.emedicalnews.net